載入...
Impact of a New Fusion Receptor on PD-1–Mediated Immunosuppression in Adoptive T Cell Therapy
BACKGROUND: Adoptive T cell transfer (ACT) is currently under investigation for the treatment of metastatic cancer. Recent evidence suggests that the coinhibitory PD-1-PD-L1 axis plays a major role in ACT failure. We hypothesized that a new fusion receptor reverting PD-1–mediated inhibition into CD2...
Na minha lista:
| 發表在: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609553/ https://ncbi.nlm.nih.gov/pubmed/26105028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv146 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|